Medicines Marketed by Dr. Morepen Limited

About Dr. Morepen Limited

Dr. Morepen Limited, a subsidiary of Morepen Laboratories Limited, has been a prominent player in the pharmaceutical and healthcare sector for over four decades. With a dedication to providing high-quality healthcare solutions, the company has undergone a transformative journey since its establishment, cementing its position as a beacon of excellence in the industry.

Based in Baddi, Himachal Pradesh, Dr. Morepen Limited boasts a robust global footprint, exporting its products to over 80 countries. Domestically, its brands, including Dr. Morepen and Gubb World, cater to the needs of over 100 million consumers, showcasing its significant presence both locally and globally.

Dr. Morepen Limited Products

Dr. Morepen Limited is involved in the manufacturing, production, development, and marketing of a diverse range of pharmaceutical products. The company is a global leader in bulk drug API production, offering products such as apixaban, linagliptin, empagliflozin, rosuvastatin, rivaroxaban, febuxostat, and montelukast. Additionally, Dr. Morepen Limited produces a variety of finished formulations, including Intebact capsules, Rythmix Kid syrup, and Kompact powder. The company also offers a range of home health products like air purifiers, vaporisers, compressor nebulisers, and stethoscopes.

Dr. Morepen Limited's products are manufactured in state-of-the-art facilities adhering to global safety and efficacy standards, including Good Manufacturing Practices (GMP), ensuring high-quality products. The company holds certifications from esteemed regulatory authorities such as USFDA, WHO GMP, and EU GMP, demonstrating its commitment to stringent quality standards. With an extensive R&D infrastructure, Dr. Morepen Limited stays at the forefront of the generic pharmaceutical revolution.